Close
Achema middle east
swop processing & packaging

Mylan Labs to buy SMS Indian manufacturing unit

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

As the U.S. production investments continue to roll in...

AstraZeneca Plant Expansion to Double Production of Lokelma

AstraZeneca has gone on to announce a newly expanded manufacturing...

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression...

Precision Formulation in Personalized Medicine

Personalized Medicine and the Future of Precision Formulation The medical...

Mylan Laboratories has agreed to purchase SMS Pharmaceuticals’ manufacturing unit-VI in Visakhapatnam, Andhra Pradesh, India, for a total sum of INR1.73bn ($33m).

The manufacturing unit was designed for the production of cancer medications and the active ingredients for cancer drugs.

SMS will use the proceeds to clear some of its existing debts, cut overhead costs, reports the Hindu Business Line.

In addition, SMS will use the finance to strengthen its existing production facilities and working capital.

SMS Pharma, which is involved in active pharmaceutical intermediaries manufacturing, said the legal process would take a couple of months.

 

Latest stories

Related stories

LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood

As the U.S. production investments continue to roll in...

AstraZeneca Plant Expansion to Double Production of Lokelma

AstraZeneca has gone on to announce a newly expanded manufacturing...

Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON

Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression...

Precision Formulation in Personalized Medicine

Personalized Medicine and the Future of Precision Formulation The medical...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »